Drug Type Small molecule drug |
Synonyms Eupatilin/jaceosidin, Jaceosidin/eupatilin, Stillen + [2] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (29 Apr 2005), |
Regulation- |
Molecular FormulaC18H16O7 |
InChIKeyDRRWBCNQOKKKOL-UHFFFAOYSA-N |
CAS Registry22368-21-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Gastritis | South Korea | 29 Apr 2005 | |
Stomach Ulcer | South Korea | 29 Apr 2005 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anaphylaxis | Discovery | South Korea | 20 Mar 2005 | |
Anaphylaxis | Discovery | South Korea | 20 Mar 2005 |
Not Applicable | - | ntumlzyzzf(chuibbycza) = gfzzbzyofm vcrgmeosix (mewvcxzozf ) | - | 09 Oct 2022 | |||
ntumlzyzzf(chuibbycza) = rvdisrnpij vcrgmeosix (mewvcxzozf ) | |||||||
Not Applicable | Diabetes Mellitus, Type 2 eNOS activity | 119 | AHT with Eupatilin | kazmfvpqif(eswanpgefv) = mpekmkclcz gmgiopaxud (chkezagpyk ) | Positive | 02 Oct 2021 | |
AHT alone | kazmfvpqif(eswanpgefv) = ebnlumpsra gmgiopaxud (chkezagpyk ) | ||||||
Not Applicable | - | yautwpirks(cnchrqyfhe) = ddmhykrrjj lyyodxmema (udgoebcftb ) | - | 01 Oct 2019 | |||
Pantoprazole 40mg + Placebo | yautwpirks(cnchrqyfhe) = kobzwawxxi lyyodxmema (udgoebcftb ) | ||||||
Phase 3 | 434 | zxaxncblzw(bceanzufph) = AEs were reported in 18 (8.4%) patients in the DA-5204 group and 19 (8.8%) in the DA-9601 group ezcntroyja (qawtjvgect ) | Positive | 01 Nov 2017 | |||
Phase 3 | 421 | DA-5204 (90 mg, b.i.d.) | sdmotmjcbm(snbmnfklow) = utdgkshubc wrvlcqqazm (jbmljqzpkb ) View more | Positive | 01 Oct 2016 | ||
DA-9601 (60 mg, t.i.d.) | sdmotmjcbm(snbmnfklow) = ymvqvrdtph wrvlcqqazm (jbmljqzpkb ) View more |